BOT
BOTANIX FPO [BOT]
Healthcare · ASX Small Cap
$0.0530 -5.4%
Updated 2026-03-02 · Scores refresh every scan
Appeared in 2 consecutive scans→ Score +10First seen: 2026-02-25
Score Breakdown
Technical38
Catalyst50
Sentiment50
Fundamental73
Momentum32
Risk Gate50
Active Signals
Bullish Signals
- RSI oversold (potential bounce)
- Stochastic oversold
- Sustained volume spike (2.0x median) on DOWN trend
- Volatility contracting (breakout setup)
- Critical cash runway (1.6 quarters)
- Moderate P/S ratio (5.8x)
- Strong revenue growth (+528%)
- EPS estimates revised upward (+10pts)
- Near 52-week low (0% of range)
- CANSLIM I: Institutional ownership (17%)
- Severe 12-1 momentum decline (-76%)
- Poor risk-adjusted momentum (Sharpe -1.8)
- Strong revenue momentum (+528%)
- ASX200 bullish (+1.5% 5d)
- RBA cutting (+2pts)
- Trial readout: PHASE3 (est. 2020-01-27)
Risk Signals
- Price below MAs (downtrend)
- Breakdown below 20-day support
- Negative 5-day momentum (-5.4%)
- Below 200-day MA (long-term downtrend)
- Insufficient sentiment data (defaulting to neutral)
- Neutral/mixed sentiment
Recent Catalysts
NONE Letter to Shareholders - Notice of General Meeting
NONE Notice of General Meeting/Proxy Form
NONE ASX Waiver for General Meeting
Recent ASX Announcements
| 2026-03-01 | Letter to Shareholders - Notice of General Meeting |
| 2026-03-01 | Notice of General Meeting/Proxy Form |
| 2026-03-01 | ASX Waiver for General Meeting |
| 2026-03-01 | Correction - Appendix 4D |
| 2026-02-27 | Appendix 4D and Half Year Report PRICE SENSITIVE |
Key Metrics
$124.2M
Market Cap
15.1M
Avg Volume
2.0x
Vol Ratio
$0.06 — $0.48
52-Week Range
2.1%
Short Interest
N/A
Cash Runway
-121.1%
ROE
N/A
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: 0% |
| A | Annual Earnings | fail | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | neutral | Float: 79% |
| L | Leader vs Laggard | laggard | RS: -11 |
| I | Institutional Sponsorship | pass | Inst: 17% |
| M | Market Direction | pass | Bullish |
Sector: Healthcare
Ranked #14 of 119 · Sector avg: 51
View all Healthcare signals →